Page last updated: 2024-12-11

ergosterol-5,8-peroxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ergosterol-5,8-peroxide: also inhibits sulfatase; isolated from fungus Cercospora kikuchii; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ergosterol peroxide : An ergostanoid that is ergosta-6,22-dien-3-ol with a peroxy group between positions 5 and 8 (the 3beta,5alpha,8alpha,22E stereoisomer). Isolated from Ganoderma lucidum and Cordyceps sinensis, it exhibits antimycobacterial, trypanocidal and antineoplastic activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5351516
CHEMBL ID434750
CHEBI ID65858
SCHEMBL ID3281353
MeSH IDM0110123

Synonyms (52)

Synonym
5alpha,8alpha-epidioxyergosta-6,22-diene-3beta-ol
5alpha,8alpha-epidioxyergosta-6,22-dien-3beta-ol
bdbm50334064
(1s,2r,5r,6r,9r,10r,13s,15s)-5-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0^{1,9}.0^{2,6}.0^{10,15}]nonadec-18-en-13-ol
peroxyergosterol
nsc-31324
ergosterol peroxide
ergosterol endoperoxide
ergosterol 5.alpha.,8.alpha.-epidioxide
2061-64-5
5.alpha.,22-dien-3.beta.-ol, 5,8-epidioxy-
ergosta-6, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22e)-
NSC31324 ,
ergosterol-5,8-peroxide
ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3-beta,5-alpha,8-alpha,22e)-
ergosterol 5alpha,8alpha-epidioxide
5,8-epidioxy-5-alpha,8-alpha-ergosta-6,22-dien-3-beta-ol
nsc 31324
ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3beta,5alpha,8alpha,22e)-
ergosterol 5-alpha,8-alpha-epidioxide
brn 0096852
5alpha,8alpha-ergosta-6,22-dien-3beta-ol, 5,8-epidioxy-
5-alpha,8-alpha-ergosta-6,22-dien-3-beta-ol, 5,8-epidioxy-
CHEMBL434750 ,
chebi:65858 ,
ug9tn81tgh ,
5-19-03-00043 (beilstein handbook reference)
unii-ug9tn81tgh
(3s,5s,8s,9r,10r,13r,14r,17r)-17-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-2h-5,8-epidioxycyclopenta[a]phenanthren-3-ol
(22e,24r)-5alpha,8alpha-epidioxyergosta-6,22-dien-3beta-ol
(24r)-5alpha,8alpha-epidioxy-24-methylcholesta-6,22-dien-3beta-ol
(3beta,5alpha,8alpha,22e)-5,8-epidioxyergosta-6,22-dien-3-ol
5alpha,8alpha-epidioxy-22e-ergosta-6,22-dien-3beta-ol
ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22e)-
5.alpha.,8.alpha.-ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-
(22e,24r)-5.alpha.,8.alpha.-epidioxyergosta-6,22-dien-3.beta.-ol
5.alpha.,8.alpha.-epidoxy-(22e,24r)-ergosta-6,22-dien-3.beta.-ol
(22e)-5.alpha.,8.alpha.-epidioxyergosta-6,22-dien-3.beta.-ol
ergosteryl peroxide
ergosterol endoperoxide [inci]
ergosterol 5,8-peroxide
(24r)-ergost-5.alpha.,8.alpha.-epidioxy-6,22-dien-3.beta.-ol
3.beta.-hydroxy-5.alpha.,8.alpha.-epidioxyergosta-6,22-diene
5.alpha.,8.alpha.-epidioxyergosterol
SCHEMBL3281353
ergosterol peroxide_120246
Q5385831
(1s,2r,5r,6r,9r,10r,13s,15s)-5-[(e,2r,5r)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol
DTXSID501021533
CS-0024320
HY-N3845
AKOS040760078
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antimycobacterial drugA drug used to treat or prevent infections caused by Mycobacteria, a genus of actinobacteria. Aerobic and nonmotile, members of the genus include the pathogens responsible for causing tuberculosis and leprosy.
trypanocidal drugA drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
organic peroxideCompounds of structure ROOR' in which R and R' are organic groups.
ergostanoid
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
phytosterolsSterols similar to cholesterol which occur in plants and vary only in carbon side chains and/or presence or absence of a double bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nitric oxide synthase, inducibleMus musculus (house mouse)IC50 (µMol)6.30000.00103.39119.6000AID552870
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinoic acid receptor RXR-alphaMus musculus (house mouse)EC50 (µMol)0.85000.04001.71805.0000AID629094
Bile acid receptorMus musculus (house mouse)EC50 (µMol)0.85000.15202.04315.0000AID629094
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
nucleoplasmRetinoic acid receptor RXR-alphaMus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (49)

Assay IDTitleYearJournalArticle
AID606486Cytotoxicity against african green monkey Vero cells at 200 uM after 72 hrs by MTS assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Antituberculosis cycloartane triterpenoids from Radermachera boniana.
AID552870Inhibition of iNOS in mouse BV2 microglial cells assessed as NO production2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
AID337803Cytotoxicity against human KB cells after 4 days
AID550017Antiinflammatory activity in human PMNC cells assessed as inhibition of fMLP-induced NOX-dependent ROS production up to 50 uM2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Camphoratins A-J, potent cytotoxic and anti-inflammatory triterpenoids from the fruiting body of Taiwanofungus camphoratus.
AID309816Antibacterial activity against Mycobacterium tuberculosis H37Rv by microdilution resazurin assay2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID550015Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced iNOS-dependent nitrite production after 24 hrs by Griess method2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Camphoratins A-J, potent cytotoxic and anti-inflammatory triterpenoids from the fruiting body of Taiwanofungus camphoratus.
AID736895Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production by Griess reaction method2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum.
AID384037Cytotoxicity against human SNU1 cells2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Bioactive peroxides as potential therapeutic agents.
AID606484Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Antituberculosis cycloartane triterpenoids from Radermachera boniana.
AID550016Antiinflammatory activity in mouse BV2 cells assessed as inhibition of NOX-dependent ROS production up to 50 uM2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Camphoratins A-J, potent cytotoxic and anti-inflammatory triterpenoids from the fruiting body of Taiwanofungus camphoratus.
AID552869Inhibition of NOX in fMLP-induced PMN cells assessed as NO production2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
AID1256622Stimulation of NGF-mediated neurite outgrowth in rat PC12 cells at 10 and 20 uM after 48 hrs by inverted microscopic analysis2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID552868Inhibition of mouse NOX activity in NADPH-induced mouse BV2 microglial cells assessed as NO production2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Biologically active constituents from the fruiting body of Taiwanofungus camphoratus.
AID736897Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum.
AID384041Inhibition of rat lens aldose reductase2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Bioactive peroxides as potential therapeutic agents.
AID713897Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID652956Inhibition of NGF-mediated neurite outgrowth in rat PC12 cells after 24 hrs by light microscopy2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Scabronine M, a novel inhibitor of NGF-induced neurite outgrowth from PC12 cells from the fungus Sarcodon scabrosus.
AID744421Cytotoxicity against human HepG2 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID384039Cytotoxicity against human SNUC4 cells2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Bioactive peroxides as potential therapeutic agents.
AID1676605Cytotoxicity against human MCF7 cells assessed as 17beta-estradiol-induced reduction in cell viability at 100 uM after 24 hrs by MTT assay
AID744422Cytotoxicity against human Hep3B cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID629093Antiinflammatory activity in human HUVEC cells assessed as inhibition of TNF-alpha-induced E-selectin mRNA expression at 5 uM for 10 mins measured after 4 hrs of LPS challenge by Q-PCR analysis2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
AID629059Antiinflammatory activity in human HUVEC cells assessed as inhibition of TNF-alpha-induced IL-8 mRNA expression at 5 uM for 10 mins measured after 4 hrs of LPS challenge by Q-PCR analysis2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
AID1256624Effect on neurite outgrowth in rat PC12 cells at 10 and 20 uM after 48 hrs by inverted microscopic analysis2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID629058Antiinflammatory activity in human HUVEC cells assessed as inhibition of LPS-induced IL-8 mRNA expression at 5 uM for 10 mins measured after 4 hrs of LPS challenge by Q-PCR analysis2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
AID736896Cytotoxicity against LPS-stimulated mouse RAW264.7 cells assessed as cell viability at 50 uM after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum.
AID1607865Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production2019European journal of medicinal chemistry, Oct-01, Volume: 179Human disorders associated with inflammation and the evolving role of natural products to overcome.
AID309818Antibacterial activity against Escherichia coli ATCC 259232007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID744420Cytotoxicity against human MCF7 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID744418Cytotoxicity against human A549 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID309817Antibacterial activity against staphylococcus aureus ATCC 259232007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID629092Antiinflammatory activity in human HUVEC cells assessed as inhibition of LPS-induced E-selectin mRNA expression at 5 uM for 10 mins measured after 4 hrs of LPS challenge by Q-PCR analysis2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
AID1256621Cytotoxicity against rat PC12 cells assessed as cell viability at 10 and 20 uM after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID1896139Antiviral activity against HBV infected human DMSO differentiated HuS-E/2 cells overexpressing NTCP assessed as assessed as inhibition of viral entry by measuring HBV mRNA level by qPCR analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
AID713904Selectivity index, ratio of IC50 for african green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID1676606Cytotoxicity against human MCF7 cells assessed as reduction in cell viability <= 100 uM after 24 hrs by MTT assay
AID629094Agonist activity at full length mouse FXR/RXRalpha expressed in human HEK293 cells assessed as induction of transcriptional activity after 18 hrs by dual luciferase reporter gene assay2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
AID1676603Cytotoxicity against human MCF7 cells assessed as reduction in cell viability at 100 nM after 24 hrs in presence of ER antagonist ICI 182,780 by MTT assay
AID309820Antifungal activity against Candida sp.2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID337802Cytotoxicity against human PLC/PRF/5 cells after 4 days
AID629057Agonist activity at FXR in human HepG2 cells assessed as inhibition of CYP7A1 mRNA expression at 50 uM for 6 hrs by RT-PCR relative to control2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
AID384038Cytotoxicity against human SNU354 cells2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Bioactive peroxides as potential therapeutic agents.
AID277524Cytotoxicity against murine B16 cells by MTT assay2007Journal of natural products, Feb, Volume: 70, Issue:2
Metabolites from the Lichen Ochrolechia parella growing under two different heliotropic conditions.
AID309819Antibacterial activity against Pseudomonas aeruginosa ATCC 277532007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID1896138Antiviral activity against HBV infected human DMSO differentiated HuS-E/2 cells overexpressing NTCP assessed as assessed as inhibition of viral entry by measuring HBV mRNA level at 20 uM by qPCR analysis relative to control2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
AID489305Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 weeks by microbroth dilution method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum.
AID744419Cytotoxicity against human MDA-MB-231 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID489306Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in stationary phase culture at pH 5.8 up to 200 ug/ml after 3 days followed by washout from day 4 to week 4 by microbroth dilution method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum.
AID384040Cytotoxicity against mouse sarcoma 180 cells2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Bioactive peroxides as potential therapeutic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (99)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.03)18.7374
1990's4 (4.04)18.2507
2000's30 (30.30)29.6817
2010's44 (44.44)24.3611
2020's18 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.70 (24.57)
Research Supply Index4.62 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (6.93%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other94 (93.07%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]